| Date Filed | Type | Description |
| 10/04/2023 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 490 shares
@ $51.1, valued at
$25k
Exercised 490 options to buy
@ $21.1, valued at
$10.3k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 538 shares
@ $55.16, valued at
$29.7k
|
|
| 03/14/2023 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 634 shares
@ $43.47, valued at
$27.6k
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2022 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 29,074 options to buy
@ $21.1, valued at
$613.5k
Granted 29,074 options to buy
@ $21.1, valued at
$613.5k
|
|
| 01/11/2022 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Exercised 26,296 options to buy
@ $0.615, valued at
$16.2k
Exercised 1,448 options to buy
@ $0.615, valued at
$890.5 |
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2021 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 18,780 shares
@ $24.27, valued at
$455.8k
Sold 6,220 shares
@ $24.33, valued at
$151.3k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Exercised 9,000 options to buy
@ $0.615, valued at
$5.5k
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 1,245 shares
@ $17.068, valued at
$21.2k
Granted 77,580 options to buy
@ $28.35, valued at
$2.2M
|
|
| 03/16/2020 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Exercised 5,035 options to buy
@ $0.615, valued at
$3.1k
Exercised 6,082 options to buy
@ $0.615, valued at
$3.7k
|
|
| 01/10/2020 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Exercised 17,621 options to buy
@ $0.615, valued at
$10.8k
Exercised 21,286 options to buy
@ $0.615, valued at
$13.1k
|
|
| 12/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 85,000 options to buy
@ $21.09, valued at
$1.8M
|
|
| 06/19/2019 |
3
| Young Jonathan (EVP, COO) has filed a Form 3 on Akero Therapeutics, Inc. |